Background Antiretroviral therapy (ART) for HIV has significantly reduced morbidity and mortality, but the drugs can be expensive. This study aimed to estimate lifetime cost of management from Australian healthcare perspective. Methods A Markov cohort model, consisting 21 health states based on CD4 count line ART, simulated disease progression over persons living with HIV. We reported costs usi...